Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning
Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment and to detect predictors of membership to the worsening trajectory. On...
Gespeichert in:
Veröffentlicht in: | Psychological medicine 2024-04, Vol.54 (6), p.1142-1151 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1151 |
---|---|
container_issue | 6 |
container_start_page | 1142 |
container_title | Psychological medicine |
container_volume | 54 |
creator | Banerjee, Samprit Wu, Yiyuan Bingham, Kathleen S Marino, Patricia Meyers, Barnett S Mulsant, Benoit H Neufeld, Nicholas H Oliver, Lindsay D Power, Jonathan D Rothschild, Anthony J Sirey, Jo Anne Voineskos, Aristotle N Whyte, Ellen M Alexopoulos, George S Flint, Alastair J |
description | Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment and to detect predictors of membership to the worsening trajectory.
One hundred and twenty-six persons aged 18-85 years participated in a 36-week randomized placebo-controlled trial (RCT) that examined the clinical effects of continuing olanzapine once an episode of MDDPsy had remitted with sertraline plus olanzapine. Latent class mixed modeling was used to identify subgroups of participants with distinct trajectories of depression severity during the RCT. Machine learning was used to predict membership to the trajectories based on participant pre-trajectory characteristics.
Seventy-one (56.3%) participants belonged to a subgroup with a stable trajectory of depression scores and 55 (43.7%) belonged to a subgroup with a worsening trajectory. A random forest model with high prediction accuracy (AUC of 0.812) found that the strongest predictors of membership to the worsening subgroup were residual depression symptoms at onset of remission, followed by anxiety score at RCT baseline and age of onset of the first lifetime depressive episode. In a logistic regression model that examined depression score at onset of remission as the only predictor variable, the AUC (0.778) was close to that of the machine learning model.
Residual depression at onset of remission has high accuracy in predicting membership to worsening outcome of remitted MDDPsy. Research is needed to determine how best to optimize the outcome of psychotic MDDPsy with residual symptoms. |
doi_str_mv | 10.1017/S0033291723002945 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2875851482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3030972018</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324t-c0be015dd6d12af3d21e13de1ed525599e60192727cfc3571b235f53a6a582b73</originalsourceid><addsrcrecordid>eNplUclOwzAQtRCIlsIHcEGRuHAJeOw4drihik2qxIFyjhx7Ql1lKXYi1L8noYUDnJ5m3qLRPELOgV4DBXnzSinnLAPJOKUsS8QBmUKSZrHKpDok05GOR35CTkJYUwocEnZMJlwqUKlIp6Raer1G07XeYYjaMvJYu65DG23C1qzazpnI4sZjCK5tbiNnselc6Yzuhnk0DJx1Y8C3_XNAbFzzHhXbqNZm5RqMKtR-3J2So1JXAc_2OCNvD_fL-VO8eHl8nt8tYsNZ0sWGFkhBWJtaYLrklgECtwhoBRMiyzClkDHJpCkNFxIKxkUpuE61UKyQfEaudrkb3370GLq8dsFgVekG2z7kTEmhBCSKDdLLP9J12_tmuC7nlNNMMgpqUMFOZXwbgscy33hXa7_NgeZjFfm_KgbPxT65L2q0v46f3_MvS0GEnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3030972018</pqid></control><display><type>article</type><title>Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>MEDLINE</source><source>Cambridge University Press Journals Complete</source><creator>Banerjee, Samprit ; Wu, Yiyuan ; Bingham, Kathleen S ; Marino, Patricia ; Meyers, Barnett S ; Mulsant, Benoit H ; Neufeld, Nicholas H ; Oliver, Lindsay D ; Power, Jonathan D ; Rothschild, Anthony J ; Sirey, Jo Anne ; Voineskos, Aristotle N ; Whyte, Ellen M ; Alexopoulos, George S ; Flint, Alastair J</creator><creatorcontrib>Banerjee, Samprit ; Wu, Yiyuan ; Bingham, Kathleen S ; Marino, Patricia ; Meyers, Barnett S ; Mulsant, Benoit H ; Neufeld, Nicholas H ; Oliver, Lindsay D ; Power, Jonathan D ; Rothschild, Anthony J ; Sirey, Jo Anne ; Voineskos, Aristotle N ; Whyte, Ellen M ; Alexopoulos, George S ; Flint, Alastair J ; STOP-PD II Study Group</creatorcontrib><description>Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment and to detect predictors of membership to the worsening trajectory.
One hundred and twenty-six persons aged 18-85 years participated in a 36-week randomized placebo-controlled trial (RCT) that examined the clinical effects of continuing olanzapine once an episode of MDDPsy had remitted with sertraline plus olanzapine. Latent class mixed modeling was used to identify subgroups of participants with distinct trajectories of depression severity during the RCT. Machine learning was used to predict membership to the trajectories based on participant pre-trajectory characteristics.
Seventy-one (56.3%) participants belonged to a subgroup with a stable trajectory of depression scores and 55 (43.7%) belonged to a subgroup with a worsening trajectory. A random forest model with high prediction accuracy (AUC of 0.812) found that the strongest predictors of membership to the worsening subgroup were residual depression symptoms at onset of remission, followed by anxiety score at RCT baseline and age of onset of the first lifetime depressive episode. In a logistic regression model that examined depression score at onset of remission as the only predictor variable, the AUC (0.778) was close to that of the machine learning model.
Residual depression at onset of remission has high accuracy in predicting membership to worsening outcome of remitted MDDPsy. Research is needed to determine how best to optimize the outcome of psychotic MDDPsy with residual symptoms.</description><identifier>ISSN: 0033-2917</identifier><identifier>ISSN: 1469-8978</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291723002945</identifier><identifier>PMID: 37818656</identifier><language>eng</language><publisher>England: Cambridge University Press</publisher><subject>Accuracy ; Age of onset ; Clinical trials ; Delusions ; Depression ; Depressive Disorder, Major - diagnosis ; Depressive Disorder, Major - drug therapy ; Drug dosages ; Hallucinations ; Humans ; Learning algorithms ; Machine learning ; Membership ; Mental depression ; Olanzapine ; Olanzapine - therapeutic use ; Psychosis ; Psychotic Disorders - drug therapy ; Psychotic symptoms ; Remission ; Remission (Medicine) ; Residual symptoms ; Sertraline ; Sertraline - therapeutic use</subject><ispartof>Psychological medicine, 2024-04, Vol.54 (6), p.1142-1151</ispartof><rights>Copyright © The Author(s), 2023. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c324t-c0be015dd6d12af3d21e13de1ed525599e60192727cfc3571b235f53a6a582b73</cites><orcidid>0000-0001-6806-0235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,12827,27903,27904,30978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37818656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Banerjee, Samprit</creatorcontrib><creatorcontrib>Wu, Yiyuan</creatorcontrib><creatorcontrib>Bingham, Kathleen S</creatorcontrib><creatorcontrib>Marino, Patricia</creatorcontrib><creatorcontrib>Meyers, Barnett S</creatorcontrib><creatorcontrib>Mulsant, Benoit H</creatorcontrib><creatorcontrib>Neufeld, Nicholas H</creatorcontrib><creatorcontrib>Oliver, Lindsay D</creatorcontrib><creatorcontrib>Power, Jonathan D</creatorcontrib><creatorcontrib>Rothschild, Anthony J</creatorcontrib><creatorcontrib>Sirey, Jo Anne</creatorcontrib><creatorcontrib>Voineskos, Aristotle N</creatorcontrib><creatorcontrib>Whyte, Ellen M</creatorcontrib><creatorcontrib>Alexopoulos, George S</creatorcontrib><creatorcontrib>Flint, Alastair J</creatorcontrib><creatorcontrib>STOP-PD II Study Group</creatorcontrib><title>Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning</title><title>Psychological medicine</title><addtitle>Psychol Med</addtitle><description>Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment and to detect predictors of membership to the worsening trajectory.
One hundred and twenty-six persons aged 18-85 years participated in a 36-week randomized placebo-controlled trial (RCT) that examined the clinical effects of continuing olanzapine once an episode of MDDPsy had remitted with sertraline plus olanzapine. Latent class mixed modeling was used to identify subgroups of participants with distinct trajectories of depression severity during the RCT. Machine learning was used to predict membership to the trajectories based on participant pre-trajectory characteristics.
Seventy-one (56.3%) participants belonged to a subgroup with a stable trajectory of depression scores and 55 (43.7%) belonged to a subgroup with a worsening trajectory. A random forest model with high prediction accuracy (AUC of 0.812) found that the strongest predictors of membership to the worsening subgroup were residual depression symptoms at onset of remission, followed by anxiety score at RCT baseline and age of onset of the first lifetime depressive episode. In a logistic regression model that examined depression score at onset of remission as the only predictor variable, the AUC (0.778) was close to that of the machine learning model.
Residual depression at onset of remission has high accuracy in predicting membership to worsening outcome of remitted MDDPsy. Research is needed to determine how best to optimize the outcome of psychotic MDDPsy with residual symptoms.</description><subject>Accuracy</subject><subject>Age of onset</subject><subject>Clinical trials</subject><subject>Delusions</subject><subject>Depression</subject><subject>Depressive Disorder, Major - diagnosis</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Drug dosages</subject><subject>Hallucinations</subject><subject>Humans</subject><subject>Learning algorithms</subject><subject>Machine learning</subject><subject>Membership</subject><subject>Mental depression</subject><subject>Olanzapine</subject><subject>Olanzapine - therapeutic use</subject><subject>Psychosis</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Psychotic symptoms</subject><subject>Remission</subject><subject>Remission (Medicine)</subject><subject>Residual symptoms</subject><subject>Sertraline</subject><subject>Sertraline - therapeutic use</subject><issn>0033-2917</issn><issn>1469-8978</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNplUclOwzAQtRCIlsIHcEGRuHAJeOw4drihik2qxIFyjhx7Ql1lKXYi1L8noYUDnJ5m3qLRPELOgV4DBXnzSinnLAPJOKUsS8QBmUKSZrHKpDok05GOR35CTkJYUwocEnZMJlwqUKlIp6Raer1G07XeYYjaMvJYu65DG23C1qzazpnI4sZjCK5tbiNnselc6Yzuhnk0DJx1Y8C3_XNAbFzzHhXbqNZm5RqMKtR-3J2So1JXAc_2OCNvD_fL-VO8eHl8nt8tYsNZ0sWGFkhBWJtaYLrklgECtwhoBRMiyzClkDHJpCkNFxIKxkUpuE61UKyQfEaudrkb3370GLq8dsFgVekG2z7kTEmhBCSKDdLLP9J12_tmuC7nlNNMMgpqUMFOZXwbgscy33hXa7_NgeZjFfm_KgbPxT65L2q0v46f3_MvS0GEnw</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Banerjee, Samprit</creator><creator>Wu, Yiyuan</creator><creator>Bingham, Kathleen S</creator><creator>Marino, Patricia</creator><creator>Meyers, Barnett S</creator><creator>Mulsant, Benoit H</creator><creator>Neufeld, Nicholas H</creator><creator>Oliver, Lindsay D</creator><creator>Power, Jonathan D</creator><creator>Rothschild, Anthony J</creator><creator>Sirey, Jo Anne</creator><creator>Voineskos, Aristotle N</creator><creator>Whyte, Ellen M</creator><creator>Alexopoulos, George S</creator><creator>Flint, Alastair J</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6806-0235</orcidid></search><sort><creationdate>20240401</creationdate><title>Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning</title><author>Banerjee, Samprit ; Wu, Yiyuan ; Bingham, Kathleen S ; Marino, Patricia ; Meyers, Barnett S ; Mulsant, Benoit H ; Neufeld, Nicholas H ; Oliver, Lindsay D ; Power, Jonathan D ; Rothschild, Anthony J ; Sirey, Jo Anne ; Voineskos, Aristotle N ; Whyte, Ellen M ; Alexopoulos, George S ; Flint, Alastair J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324t-c0be015dd6d12af3d21e13de1ed525599e60192727cfc3571b235f53a6a582b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accuracy</topic><topic>Age of onset</topic><topic>Clinical trials</topic><topic>Delusions</topic><topic>Depression</topic><topic>Depressive Disorder, Major - diagnosis</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Drug dosages</topic><topic>Hallucinations</topic><topic>Humans</topic><topic>Learning algorithms</topic><topic>Machine learning</topic><topic>Membership</topic><topic>Mental depression</topic><topic>Olanzapine</topic><topic>Olanzapine - therapeutic use</topic><topic>Psychosis</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Psychotic symptoms</topic><topic>Remission</topic><topic>Remission (Medicine)</topic><topic>Residual symptoms</topic><topic>Sertraline</topic><topic>Sertraline - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Banerjee, Samprit</creatorcontrib><creatorcontrib>Wu, Yiyuan</creatorcontrib><creatorcontrib>Bingham, Kathleen S</creatorcontrib><creatorcontrib>Marino, Patricia</creatorcontrib><creatorcontrib>Meyers, Barnett S</creatorcontrib><creatorcontrib>Mulsant, Benoit H</creatorcontrib><creatorcontrib>Neufeld, Nicholas H</creatorcontrib><creatorcontrib>Oliver, Lindsay D</creatorcontrib><creatorcontrib>Power, Jonathan D</creatorcontrib><creatorcontrib>Rothschild, Anthony J</creatorcontrib><creatorcontrib>Sirey, Jo Anne</creatorcontrib><creatorcontrib>Voineskos, Aristotle N</creatorcontrib><creatorcontrib>Whyte, Ellen M</creatorcontrib><creatorcontrib>Alexopoulos, George S</creatorcontrib><creatorcontrib>Flint, Alastair J</creatorcontrib><creatorcontrib>STOP-PD II Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Banerjee, Samprit</au><au>Wu, Yiyuan</au><au>Bingham, Kathleen S</au><au>Marino, Patricia</au><au>Meyers, Barnett S</au><au>Mulsant, Benoit H</au><au>Neufeld, Nicholas H</au><au>Oliver, Lindsay D</au><au>Power, Jonathan D</au><au>Rothschild, Anthony J</au><au>Sirey, Jo Anne</au><au>Voineskos, Aristotle N</au><au>Whyte, Ellen M</au><au>Alexopoulos, George S</au><au>Flint, Alastair J</au><aucorp>STOP-PD II Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol Med</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>54</volume><issue>6</issue><spage>1142</spage><epage>1151</epage><pages>1142-1151</pages><issn>0033-2917</issn><issn>1469-8978</issn><eissn>1469-8978</eissn><abstract>Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment and to detect predictors of membership to the worsening trajectory.
One hundred and twenty-six persons aged 18-85 years participated in a 36-week randomized placebo-controlled trial (RCT) that examined the clinical effects of continuing olanzapine once an episode of MDDPsy had remitted with sertraline plus olanzapine. Latent class mixed modeling was used to identify subgroups of participants with distinct trajectories of depression severity during the RCT. Machine learning was used to predict membership to the trajectories based on participant pre-trajectory characteristics.
Seventy-one (56.3%) participants belonged to a subgroup with a stable trajectory of depression scores and 55 (43.7%) belonged to a subgroup with a worsening trajectory. A random forest model with high prediction accuracy (AUC of 0.812) found that the strongest predictors of membership to the worsening subgroup were residual depression symptoms at onset of remission, followed by anxiety score at RCT baseline and age of onset of the first lifetime depressive episode. In a logistic regression model that examined depression score at onset of remission as the only predictor variable, the AUC (0.778) was close to that of the machine learning model.
Residual depression at onset of remission has high accuracy in predicting membership to worsening outcome of remitted MDDPsy. Research is needed to determine how best to optimize the outcome of psychotic MDDPsy with residual symptoms.</abstract><cop>England</cop><pub>Cambridge University Press</pub><pmid>37818656</pmid><doi>10.1017/S0033291723002945</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-6806-0235</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-2917 |
ispartof | Psychological medicine, 2024-04, Vol.54 (6), p.1142-1151 |
issn | 0033-2917 1469-8978 1469-8978 |
language | eng |
recordid | cdi_proquest_miscellaneous_2875851482 |
source | Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Cambridge University Press Journals Complete |
subjects | Accuracy Age of onset Clinical trials Delusions Depression Depressive Disorder, Major - diagnosis Depressive Disorder, Major - drug therapy Drug dosages Hallucinations Humans Learning algorithms Machine learning Membership Mental depression Olanzapine Olanzapine - therapeutic use Psychosis Psychotic Disorders - drug therapy Psychotic symptoms Remission Remission (Medicine) Residual symptoms Sertraline Sertraline - therapeutic use |
title | Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A01%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trajectories%20of%20remitted%20psychotic%20depression:%20identification%20of%20predictors%20of%20worsening%20by%20machine%20learning&rft.jtitle=Psychological%20medicine&rft.au=Banerjee,%20Samprit&rft.aucorp=STOP-PD%20II%20Study%20Group&rft.date=2024-04-01&rft.volume=54&rft.issue=6&rft.spage=1142&rft.epage=1151&rft.pages=1142-1151&rft.issn=0033-2917&rft.eissn=1469-8978&rft_id=info:doi/10.1017/S0033291723002945&rft_dat=%3Cproquest_cross%3E3030972018%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3030972018&rft_id=info:pmid/37818656&rfr_iscdi=true |